Evidence map›Paper›PMID 34408135›Full record

ArticleNature communications2021

Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery.

Simone Di Franco, Paola Bianca, Davide Stefano Sardina, Alice Turdo, Miriam Gaggianesi, Veronica Veschi, Annalisa Nicotra, Laura Rosa Mangiapane, Melania Lo Iacono, Irene Pillitteri and 19 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Systematic review: The gut microbiota as a link between colorectal cancer and obesity.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Tumor Innervation: From Bystander to Emerging Therapeutic Target for Cancer.International journal of molecular sciences · 2025
    Review
  11. Review
  12. The role of adipogenic niche resident cells in colorectal cancer progression in relation to obesity.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Review
  13. C1QMolecular cancer · 2025
    Article
  14. Review
  15. Review
  16. Article
  17. Advancements in 3D In Vitro Models for Colorectal Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  18. Review
  19. Review
  20. Clinical Challenges of Consensus Molecular Subtype CMS4 Colon Cancer in the Era of Precision Medicine.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 10 institutions in 3 countries.

Simone Di FrancoDepartment of Surgical Oncological and Stomatological Sciences (DICHIRONS), University of Palermo, Palermo, Italy.ORCID 0000-0002-6217-2161
Paola BiancaDepartment of Health Promotion Sciences, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.ORCID 0000-0002-9172-0809
Davide Stefano SardinaDepartment of Health Promotion Sciences, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.ORCID 0000-0003-1161-3016
Alice TurdoDepartment of Health Promotion Sciences, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.ORCID 0000-0002-6152-4903
Miriam GaggianesiDepartment of Surgical Oncological and Stomatological Sciences (DICHIRONS), University of Palermo, Palermo, Italy.ORCID 0000-0002-7810-856X
Veronica VeschiDepartment of Surgical Oncological and Stomatological Sciences (DICHIRONS), University of Palermo, Palermo, Italy.ORCID 0000-0002-6379-7366
Annalisa NicotraDepartment of Health Promotion Sciences, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.ORCID 0000-0002-3325-4942
Laura Rosa MangiapaneDepartment of Health Promotion Sciences, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.ORCID 0000-0003-4186-0157
Melania Lo IaconoDepartment of Surgical Oncological and Stomatological Sciences (DICHIRONS), University of Palermo, Palermo, Italy.ORCID 0000-0002-9292-327X
Irene PillitteriDepartment of Surgical Oncological and Stomatological Sciences (DICHIRONS), University of Palermo, Palermo, Italy.ORCID 0000-0002-8013-218X
Sander van HooffLaboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Federica MartoranaDepartment of Clinical and Experimental Medicine, A.O.U. Policlinico-Vittorio Emanuele, Division of Medical Oncology, University of Catania, Catania, Italy.ORCID 0000-0001-5062-2914
Gianmarco MottaDepartment of Clinical and Experimental Medicine, A.O.U. Policlinico-Vittorio Emanuele, Division of Medical Oncology, University of Catania, Catania, Italy.ORCID 0000-0002-3214-5680
Eliana GulottaReconstructive Plastic Surgery, ARNAS Ospedali Civico Di Cristina e Benfratelli, Palermo, Italy.
Vincenzo Luca LentiniPathology Unit, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.ORCID 0000-0002-3679-3968
Emanuele MartoranaIOM (Mediterranean Institute of Oncology) Ricerca, Viagrande, Catania, Italy.ORCID 0000-0001-9760-887X
Micol Eleonora FioriDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.ORCID 0000-0002-1813-7035
Salvatore VieniDepartment of Surgical Oncological and Stomatological Sciences (DICHIRONS), University of Palermo, Palermo, Italy.
Maria Rita BongiornoDepartment of Health Promotion Sciences, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.
Giorgio GiannoneDepartment of Experimental Oncology, Mediterranean Institute of Oncology, Viagrande, Catania, Italy.
Dario GiuffridaDepartment of Experimental Oncology, Mediterranean Institute of Oncology, Viagrande, Catania, Italy.
Lorenzo MemeoDepartment of Experimental Oncology, Mediterranean Institute of Oncology, Viagrande, Catania, Italy.ORCID 0000-0003-4251-7203
Lorenzo ColarossiDepartment of Experimental Oncology, Mediterranean Institute of Oncology, Viagrande, Catania, Italy.ORCID 0000-0001-9988-2362
Marzia MareDepartment of Experimental Oncology, Mediterranean Institute of Oncology, Viagrande, Catania, Italy.
Paolo VigneriDepartment of Clinical and Experimental Medicine, A.O.U. Policlinico-Vittorio Emanuele, Center of Experimental Oncology and Hematology, University of Catania, Catania, Italy.ORCID 0000-0002-5943-6066
Matilde TodaroDepartment of Health Promotion Sciences, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.
Ruggero De MariaIstituto di Patologia Generale, Università Cattolica del Sacro Cuore, Rome, Italy.
Jan Paul MedemaLaboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Giorgio StassiDepartment of Surgical Oncological and Stomatological Sciences (DICHIRONS), University of Palermo, Palermo, Italy. giorgio.stassi@unipa.it.ORCID 0000-0002-1016-9059
University of Palermo · ITUniversity of Catania · ITAmsterdam University Medical Centers · NLAzienda di Rilievo Nazionale ed Alta Specializzazione · ITIstituto Superiore di Sanità · ITOncode Institute · NLOspedale Vincenzo Cervello · ITUniversità Cattolica del Sacro Cuore · ITUniversity of Messina · ITUniversity of Palermo · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity is a strong risk factor for cancer progression, posing obesity-related cancer as one of the leading causes of death. Nevertheless, the molecular mechanisms that endow cancer cells with metastatic properties in patients affected by obesity remain unexplored.Here, we show that IL-6 and HGF, secreted by tumor neighboring visceral adipose stromal cells (V-ASCs), expand the metastatic colorectal (CR) cancer cell compartment (CD44v6 + ), which in turn secretes neurotrophins such as NGF and NT-3, and recruits adipose stem cells within tumor mass. Visceral adipose-derived factors promote vasculogenesis and the onset of metastatic dissemination by activation of STAT3, which inhibits miR-200a and enhances ZEB2 expression, effectively reprogramming CRC cells into a highly metastatic phenotype. Notably, obesity-associated tumor microenvironment provokes a transition in the transcriptomic expression profile of cells derived from the epithelial consensus molecular subtype (CMS2) CRC patients towards a mesenchymal subtype (CMS4). STAT3 pathway inhibition reduces ZEB2 expression and abrogates the metastatic growth sustained by adipose-released proteins. Together, our data suggest that targeting adipose factors in colorectal cancer patients with obesity may represent a therapeutic strategy for preventing metastatic disease.

Indexed as

Cellular ReprogrammingStem Cell NicheAdipose TissueAnimalsColonic NeoplasmsHepatocyte Growth FactorHumansInterleukin-6MaleMiceMice, SCIDMicroRNAsNeoplasm MetastasisNeoplastic Stem CellsStem CellsZinc Finger E-box Binding Homeobox 2Hepatocyte Growth FactorHGF protein, mouseInterleukin-6MicroRNAsMirn200 microRNA, mouseZEB2 protein, mouseZinc Finger E-box Binding Homeobox 2

Identifiers

PMID34408135
PMCPMC8373975
OpenAlexW3194895625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.